HIV 1 News and Research

RSS

A*STAR's Singapore Immunology Network, Institut M-rieux and bioM-rieux partner in TB research

An investment of S$3 million is being pumped into tuberculosis (TB) research by A*STAR's Singapore Immunology Network (SIgN), bioindustrial group Institut M-rieux and its in vitro diagnostics company bioM-rieux. The project, which involves setting up a joint laboratory in Biopolis, Singapore aims to investigate and identify novel biomarkers that could allow early identification of individuals at risk of TB disease development and disease reactivation. This could lead to better diagnosis and treatment for the highly contagious disease.

13 Aug 2010

HIV infected injection drug users likely to have kidney disease: Study

Poor kidney function is common among injection drug users, particularly those with HIV, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that clinicians should monitor the kidney function of HIV-infected injection drug users and consider them candidates for medical treatments to protect their kidneys when appropriate.

13 Aug 2010

Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPs

Bristol-Myers Squibb Company and the ADAP Crisis Task Force today announced an enhanced agreement to support the efforts of AIDS Drug Assistance Programs to provide antiretroviral medicines to people living with HIV and AIDS. Building on an agreement signed in March of 2010, today's announcement marks a multi-year enhancement to assist ADAPs in meeting the challenges of increasing patient case loads and strained government funding.

12 Aug 2010

HIV patients want docs to pay attention to other health conditions exacerbated by HIV

HIV/AIDS patients need their doctors to pay more attention to their other health conditions that can be exacerbated by HIV or its treatments, especially now that people are living longer with HIV. That is according to a international study of 2,000 patients that two Chicago-area health providers were instrumental in carrying out.

12 Aug 2010

Early administration of TXA reduces death from bleeding without increase in complications: Study

If recently injured patients with serious bleeding were to receive a cheap, widely available and easily administered drug to help their blood to clot, tens of thousands of lives could be saved every year, according to a paper published on-line today by The Lancet.

12 Aug 2010

AHF led sustained advocacy campaign leads to BMS's offer of discounts in AIDS drug pricing

Following ongoing advocacy campaigns spearheaded by AIDS Healthcare Foundation (AHF) that targeted several of the largest AIDS drug companies over their pricing and rebate policies for the nation's AIDS Drug Assistance Programs (ADAPs), the federally funded, state run programs that supply lifesaving AIDS drugs to low-income Americans in need, that the last remaining major AIDS drug company, Bristol-Myers Squibb (BMS) today announced an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide.

12 Aug 2010

Chimpanzee adenoviruses can be used as vaccine vectors: Research

In recent years, scientists have studied the possibility of using engineered human adenoviruses as vaccines against diseases such as HIV, tuberculosis, and malaria. In this approach, adenoviruses, which commonly cause respiratory-tract infections, are rendered relatively harmless before they are used as vectors to deliver genes from pathogens, which in turn stimulate the body to generate a protective immune response.

12 Aug 2010

Opinions: HIV prevention research; Foreign aid; Sanitation; Aid, self-reliance

"Microbicides, vaccines and other new approaches will one day join proven HIV-prevention strategies, including condoms, male circumcision and clean needles. How soon that day comes will depend on whether funders and the scientific community can develop the more collaborative approaches to HIV prevention research needed to address this fast-moving epidemic," Global HIV Vaccine Enterprise leaders Alan Bernstein, executive director, and Peter Piot, chair, write in a Globe and Mail opinion piece.

11 Aug 2010

Al Shabaab demands World Vision to close operations in Somalia

World Vision Somalia received a demand today from Al Shabaab to close operations in Somalia. World Vision guards were disarmed and their keys were taken. Nothing was removed from the offices although Al Shabaab representatives occupied the offices.

10 Aug 2010

AHF launches new ad campaign 'President Obama, The War on AIDS Has Not Been Won'

As part of its ongoing advocacy efforts to spur President Obama and the Administration to do more on AIDS, AHF is rolling out an ad headlined "President Obama, The War on AIDS Has Not Been Won" which compares the amount of U.S. dollars spent fighting the global AIDS epidemic vs. the amount spent on the war in Afghanistan. The ad features a scale with the globe on one side and the words "Global War on AIDS: $6.5 billion in 2010" and a map of Afghanistan on the other side with the words "Afghanistan War: $102 billion in 2010."

10 Aug 2010

Scientists identify compound to inhibit wild-type HIV-1 protease

Drug resistance remains a major problem in combating HIV infection, but a different approach to drug development could be the answer.Current viral inhibitors target the HIV-1 protease function with a competitive mechanism. Writing in the BJ ChemBio Knowledge Environment of the Biochemical Journal, Max Chang and colleagues from the Scripps Research Institute, La Jolla, suggest that pharmaceutical companies look at compounds that use an allosteric non-competitive mechanism of inhibition.

10 Aug 2010

CQ Weekly reports on advocates' response to Obama administration's domestic, global HIV/AIDS efforts

CQ Weekly examines how HIV/AIDS advocates are "[i]Increasingly dissatisfied with [President Barack] Obama's approach, both at home and abroad." According to the article, some advocates say that Obama and congressional Democrats "have failed to show the political will and marshal the necessary resources" to fight HIV/AIDS.

10 Aug 2010

Lancet World Report examines how U.N. Women agency will work to address global health issues

A Lancet World Report article examines how many are looking to the new U.N. agency tasked with advancing women's equality and rights to help improve the health of women in developing countries.

10 Aug 2010

Female Health Company third-quarter net revenues decrease 75% to $1.8 million

The Female Health Company, which manufactures and markets the FC2 Female Condom®, today reported its operating results for the third quarter and first nine months of FY2010.

7 Aug 2010

BMS to join ranks of AIDS drug companies to offer price concessions

Bristol-Myers Squibb will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial AIDS Directors, is expected to be announced any day. BMS has been the target of a sustained advocacy campaign led by AHF over its pricing of its key AIDS drug Reyataz.

7 Aug 2010

NeurogesX net loss for second-quarter 2010 increases to $10.2 million

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for its second quarter ended June 30, 2010.

7 Aug 2010

Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs

"Pharmaceutical companies, once blasted as uncaring or downright greedy for charging thousands of dollars for a year's worth of AIDS medicines … in poor countries, lately have been slashing prices and licensing their drugs for free or nominal cost to nonprofits or local manufacturers in the developing world," Bloomberg BusinessWeek writes in an analysis piece that examines how this trend, combined with a growing capability among aid agencies to distribute drugs, has the potential to increase access to HIV/AIDS drugs worldwide.

7 Aug 2010

Clinical trials in Asia, Africa confirm safety, effectiveness of rotavirus vaccine

Two studies published online Thursday in the Lancet show that the rotavirus vaccine is safe and effective at preventing much of the gastrointestinal illness in developing countries, where rotavirus kills more than 400,000 children under age 5 annually, Reuters reports. Based on the findings in Asia and Africa, the studies' authors "urged the governments of developing nations to make the vaccines a priority," the news service writes.

7 Aug 2010

Multiple tattoos increase risk of contracting hepatitis C: Study

Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.The researchers reviewed and analysed 124 studies from 30 countries, including Canada, Iran, Italy, Brazil and the United States, and found the incidence of hepatitis C after tattooing is directly linked with the number of tattoos an individual receives. The findings are published in the current issue of the International Journal of Infectious Diseases.

7 Aug 2010

Equatorial Guinea, ECCAS partner to form network to fight H1N1, HIV

Equatorial Guinea (Republica de Guinea Ecuatorial) and the Global Viral Forecasting Initiative, along with several Central African States, have partnered with the Economic Community of Central African States to form a network to fight H1N1 and HIV. The purpose of the network's recent forum was to share knowledge and best practices, and to collect data and prevention procedures among military health professionals in the region.

7 Aug 2010

HIV 1 News and Research

A*STAR's Singapore Immunology Network, Institut M-rieux and bioM-rieux partner in TB research

HIV infected injection drug users likely to have kidney disease: Study

Bristol-Myers Squibb, ACTF announce enhanced agreement to support ADAPs

HIV patients want docs to pay attention to other health conditions exacerbated by HIV

Early administration of TXA reduces death from bleeding without increase in complications: Study

AHF led sustained advocacy campaign leads to BMS's offer of discounts in AIDS drug pricing

Chimpanzee adenoviruses can be used as vaccine vectors: Research

Opinions: HIV prevention research; Foreign aid; Sanitation; Aid, self-reliance

Al Shabaab demands World Vision to close operations in Somalia

AHF launches new ad campaign 'President Obama, The War on AIDS Has Not Been Won'

Scientists identify compound to inhibit wild-type HIV-1 protease

CQ Weekly reports on advocates' response to Obama administration's domestic, global HIV/AIDS efforts

Lancet World Report examines how U.N. Women agency will work to address global health issues

Female Health Company third-quarter net revenues decrease 75% to $1.8 million

BMS to join ranks of AIDS drug companies to offer price concessions

NeurogesX net loss for second-quarter 2010 increases to $10.2 million

Bloomberg Businessweek explores growing trend in pharma to license, donate HIV drugs

Clinical trials in Asia, Africa confirm safety, effectiveness of rotavirus vaccine

Multiple tattoos increase risk of contracting hepatitis C: Study

Equatorial Guinea, ECCAS partner to form network to fight H1N1, HIV

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News